Loading stock data…
ADUS
$92.70+1.99 (+2.19%)
After Hours$92.70+0.00 (+0.00%)· Last close Jun 9
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Addus HomeCare Corporation in the Healthcare sector is trading at $92.70. Wall Street consensus targets $132.69 (13 analysts), implying a +43.1% move over the next 12 months. The stock is currently near its 52-week low of $87.95, remaining 13.4% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +43.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$92.70
Potential Downside
0%
Whystock Fair Value$92.70
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Buy
Mean target$132.69+43.1%
Range$92.00 – $155.00
Fundamentals
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company op...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.94%
Volume
Today's trading volume
144,011
Recent News
1 Value Stock Worth Your Attention and 2 Facing Challenges
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Assessing Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness
Why Addus HomeCare Stock Is Back on Investors’ Radar Addus HomeCare (ADUS) has drawn fresh attention after a year in which the stock declined about 17% and is down about 13% year to date, despite reported revenue and net income growth. See our latest analysis for Addus HomeCare. The recent share price, at US$92.65, reflects a 90 day share price return that is down 11.93%, while the 3 year total shareholder return of 4.32% contrasts with a 1 year total shareholder return that is down 17.39%...
BrightSpring Leans Into Home Care as IRA Pricing Resets Hit
BTSG is navigating ~$600M of 2026 revenue headwinds while leaning on national scale and home-based coordination to drive margin expansion.
BTSG Q1 2026 Beat Shows Drivers of Margin Expansion
BrightSpring beat Q1 estimates as revenue rose 25.6% and margins widened; its home-based platform gains traction despite IRA-related revenue pressure.
1 Growth Stock with All-Star Potential and 2 Facing Headwinds
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.